Houllier AM - Search Results

1

Single nucleotide polymorphisms in MMP1 and MMP3 gene promoters as risk factor in head and neck squamous cell carcinoma.

Zinzindohoué F, Blons H, Hans S, Loriot MA, Houllier AM, Brasnu D, Laccourreye O, Tregouet DA, Stucker I, Laurent-Puig P. Zinzindohoué F, et al. Among authors: houllier am. Anticancer Res. 2004 May-Jun;24(3b):2021-6. Anticancer Res. 2004. PMID: 15274394 Free article.

2

Delineation and candidate gene mutation screening of the 18q22 minimal region of deletion in head and neck squamous cell carcinoma.

Blons H, Laccourreye O, Houllier AM, Carnot F, Brasnu D, Beaune P, Zucman-Rossi J, Laurent-Puig P. Blons H, et al. Among authors: houllier am. Oncogene. 2002 Jul 25;21(32):5016-23. doi: 10.1038/sj.onc.1205626. Oncogene. 2002. PMID: 12118382

3

Myeloperoxidase: new polymorphisms and relation with lung cancer risk.

Chevrier I, Stücker I, Houllier AM, Cenée S, Beaune P, Laurent-Puig P, Loriot MA. Chevrier I, et al. Among authors: houllier am. Pharmacogenetics. 2003 Dec;13(12):729-39. doi: 10.1097/01.fpc.0000054143.14659.ba. Pharmacogenetics. 2003. PMID: 14646692

4

Prognostic significance of MMP-1 and MMP-3 functional promoter polymorphisms in colorectal cancer.

Zinzindohoué F, Lecomte T, Ferraz JM, Houllier AM, Cugnenc PH, Berger A, Blons H, Laurent-Puig P. Zinzindohoué F, et al. Among authors: houllier am. Clin Cancer Res. 2005 Jan 15;11(2 Pt 1):594-9. Clin Cancer Res. 2005. PMID: 15701845

5

p53 alterations predict tumor response to neoadjuvant chemotherapy in head and neck squamous cell carcinoma: a prospective series.

Cabelguenne A, Blons H, de Waziers I, Carnot F, Houllier AM, Soussi T, Brasnu D, Beaune P, Laccourreye O, Laurent-Puig P. Cabelguenne A, et al. Among authors: houllier am. J Clin Oncol. 2000 Apr;18(7):1465-73. doi: 10.1200/JCO.2000.18.7.1465. J Clin Oncol. 2000. PMID: 10735894

6

Clinicopathological significance of mitochondrial D-Loop mutations in head and neck carcinoma.

Lièvre A, Blons H, Houllier AM, Laccourreye O, Brasnu D, Beaune P, Laurent-Puig P. Lièvre A, et al. Among authors: houllier am. Br J Cancer. 2006 Mar 13;94(5):692-7. doi: 10.1038/sj.bjc.6602993. Br J Cancer. 2006. PMID: 16495928 Free PMC article.

7

No somatic genetic change in the paxillin gene in nonsmall-cell lung cancer.

Pallier K, Houllier AM, Le Corre D, Cazes A, Laurent-Puig P, Blons H. Pallier K, et al. Among authors: houllier am. Mol Carcinog. 2009 Jul;48(7):581-5. doi: 10.1002/mc.20538. Mol Carcinog. 2009. PMID: 19353596

8

Long-term results of TPMT activity monitoring in azathioprine-treated renal allograft recipients.

Thervet E, Anglicheau D, Toledano N, Houllier AM, Noel LH, Kreis H, Beaune P, Legendre C. Thervet E, et al. Among authors: houllier am. J Am Soc Nephrol. 2001 Jan;12(1):170-176. doi: 10.1681/ASN.V121170. J Am Soc Nephrol. 2001. PMID: 11134264

9

Genetic factors (VKORC1, CYP2C9, EPHX1, and CYP4F2) are predictor variables for warfarin response in very elderly, frail inpatients.

Pautas E, Moreau C, Gouin-Thibault I, Golmard JL, Mahé I, Legendre C, Taillandier-Hériche E, Durand-Gasselin B, Houllier AM, Verrier P, Beaune P, Loriot MA, Siguret V. Pautas E, et al. Among authors: houllier am. Clin Pharmacol Ther. 2010 Jan;87(1):57-64. doi: 10.1038/clpt.2009.178. Epub 2009 Sep 30. Clin Pharmacol Ther. 2010. PMID: 19794411

10

A protein kinase C inhibitory activity is present in the human T lymphoblast cell line Jurkat.

Columelli S, Houllier AM, Pérignon JL. Columelli S, et al. Among authors: houllier am. Immunol Lett. 1991 Nov;30(3):297-300. doi: 10.1016/0165-2478(91)90041-8. Immunol Lett. 1991. PMID: 1686872

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

17 results

Search Page